Offer - Urjas Oil for just ₹ 1
Emecad is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Is the use of Emecad safe for pregnant women?
Emecad is safe for pregnant women.
Is the use of Emecad safe during breastfeeding?
Emecad may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Emecad, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Emecad.
What is the effect of Emecad on the Kidneys?
There are no side effects of Emecad on the kidneys.
What is the effect of Emecad on the Liver?
There are no any side effects of Emecad on the liver.
What is the effect of Emecad on the Heart?
Using Emecad does not have any harmful effects on the heart.
Emecad should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Emecad unless your doctor advises you to do so -
Is this Emecad habit forming or addictive?
Emecad is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Emecad since it will not make you feel sleepy.
Is it safe?
Yes, but take Emecad only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Emecad for mental disorders.
Interaction between Food and Emecad
It is safe to take Emecad with food.
Interaction between Alcohol and Emecad
Due to lack of research, there is no information about the side effects of taking Emecad with alcohol.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 899
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 669
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aloxi® (palonosetron hydrochloride)